Sherman Lawrence, Halila Hannu, Chappell Kathy
Executive Office, Meducate Global, LLC, Tierra Verde, FL, USA.
Health Care Administration, University of Helsinki, Helsinki, Finland.
J CME. 2024 Dec 4;13(1):2435731. doi: 10.1080/28338073.2024.2435731. eCollection 2024.
The aims of this assessment were to describe the requirements for European physicians to engage in CME/CPD; explore perceptions of their CME/CPD systems; interprofessional continuing education (IPCE) and independent CME/CPD and provide recommendations that may be adopted to improve quality and effectiveness. This assessment used a mixed-methods approach that included 1:1 interviews with in-country subject matter experts (SMEs) and an electronic survey capturing qualitative and quantitative data from practicing in-country physicians. Our analysis reflects countries with CME/CPD systems that are quite mature when compared to other areas of the world. Almost all the European countries have CME/CPD systems that are professionally self-regulated and have implemented policies or laws to limit the influence of pharmaceutical or device companies over content in CME/CPD. Several countries have incorporated a learning sciences framework into their systems, including self-assessment/self-reflection and evaluation of professional practice gaps. Overall quality of CME/CPD systems was described as high, with education focused on knowledge and practice change. Opportunities for improvement are focused on increasing innovation, improving transparency and consistency, and decreasing administrative burdens. About half the countries have and support IPCE, which is likely also a marker of a more mature CME/CPD system. This mixed-method assessment demonstrates that the CME/CPD systems in the 15 European countries reflect elements of mature systems globally. Physician participation is mandated or strongly encouraged and supported. Physicians have access to a wide variety of opportunities to participate in CME/CPD, and they do participate even if not required by regulation. There are mechanisms to ensure the quality of CME/CPD even when pharmaceutical or device companies are permitted to provide education. Suggestions for improvement focus on quality and not basic elements of structure.
本次评估的目的是描述欧洲医生参与继续医学教育/持续专业发展（CME/CPD）的要求；探讨他们对CME/CPD体系、跨专业继续教育（IPCE）以及独立CME/CPD的看法，并提出可采用的建议以提高质量和有效性。本评估采用了混合方法，包括与国内主题专家（SME）进行一对一访谈，以及通过电子调查收集国内执业医生的定性和定量数据。我们的分析表明，与世界其他地区相比，欧洲国家的CME/CPD体系相当成熟。几乎所有欧洲国家都有由专业自我监管的CME/CPD体系，并已实施政策或法律来限制制药或器械公司对CME/CPD内容的影响。有几个国家已将学习科学框架纳入其体系，包括自我评估/自我反思以及对专业实践差距的评估。CME/CPD体系的整体质量被描述为较高，教育侧重于知识和实践变革。改进的机会集中在增加创新、提高透明度和一致性以及减轻行政负担方面。约一半的国家拥有并支持IPCE，这可能也是更成熟的CME/CPD体系的一个标志。这种混合方法评估表明，15个欧洲国家的CME/CPD体系反映了全球成熟体系中的要素。医生参与是强制性的，或受到大力鼓励和支持。医生有广泛机会参与CME/CPD，即使法规未要求，他们也会参与。即使允许制药或器械公司提供教育，也有确保CME/CPD质量的机制。改进建议侧重于质量而非结构的基本要素。
